A data-driven approach to the development of medical devices
In the May edition of the ONdrugDelivery magazine, SHL’s Manager of Data and Process Innovation Frederick Gertz, Ph.D, provides an in-depth analysis on the advantages and challenges of becoming a data-driven organization in the medical technology sector.
In a digitalized era, where various tech giants are driving the newest data science trends and reaping results from data-driven decisions, the pharma and medical device industry seems to be moving at a relatively moderate pace. Although it is quite understandable, with life science companies having extraordinary requirements in terms of quality and regulatory standards, this article offers further insights into how digital transformation could benefit these organizations in terms of producing quality results from multiple aspects of development and production.
“Data-driven organizations can better plan logistics, adaptably shift workloads and quickly solve problems,” Gertz said. He also breaks down how transparent data could well streamline communication between designers and manufacturers, thus, giving support in developing products that warrant manufacturability and usability. “By creating a single source of truth, stakeholders across the organization can more easily interact and ultimately collaborate to make products with the highest level of value to everyone,” he explained.
As a leading solutions provider in the drug delivery industry, SHL continues to evolve and adapt to industry changes, implementing data-driven methodologies that ensure better development processes for autoinjector devices.